Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Carnevale-Schianca

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Panminerva Medica|December 1, 1995
Serial in vitro transfer of tuberculin hypersensitivity by sensitised lymphocytesM Fazio, F Carnevale-Schianca, A Sabidussi
Panminerva Medica|December 1, 1995
Serial in vitro transfer of hypersensitivity to cancer antigens by sensitised lymphocytesM Fazio, F Carnevale-Schianca, A Sabidussi
Expert Opinion on Biological Therapy|May 26, 2009
Cytokine induced killer cells as adoptive immunotherapy strategy to augment graft versus tumor after hematopoietic cell transplantationD Sangiolo, G Mesiano, F Carnevale-Schianca, et al.
Transplantation Proceedings|September 27, 2005
Allogeneic hemopoietic stem cell transplantation in solid tumorsF Carnevale-Schianca, A Ricchiardi, A Capaldi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 29, 2000
Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host diseaseF Carnevale-Schianca, P Martin, K Sullivan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 23, 2011
153Samarium-EDTMP administration followed by hematopoietic stem cell support for bone metastases in osteosarcoma patientsM Berger, G Grignani, A Giostra, et al.
Bone Marrow Transplantation|April 21, 2009
Therapy with mycophenolate mofetil for refractory acute and chronic GVHDT Furlong, P Martin, M E D Flowers, et al.
ESMO Open|May 13, 2021
High BRAF variant allele frequencies are associated with distinct pathological features and responsiveness to target therapy in melanoma patientsE Berrino, A Balsamo, A Pisacane, et al.
British Journal of Cancer|March 13, 2014
Ipilimumab retreatment in patients with pretreated advanced melanoma: the expanded access programme in ItalyV Chiarion-Sileni, J Pigozzo, P A Ascierto, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Panminerva Medica|December 1, 1995
Serial in vitro transfer of tuberculin hypersensitivity by sensitised lymphocytesM Fazio, F Carnevale-Schianca, A Sabidussi
Panminerva Medica|December 1, 1995
Serial in vitro transfer of hypersensitivity to cancer antigens by sensitised lymphocytesM Fazio, F Carnevale-Schianca, A Sabidussi
Expert Opinion on Biological Therapy|May 26, 2009
Cytokine induced killer cells as adoptive immunotherapy strategy to augment graft versus tumor after hematopoietic cell transplantationD Sangiolo, G Mesiano, F Carnevale-Schianca, et al.
Transplantation Proceedings|September 27, 2005
Allogeneic hemopoietic stem cell transplantation in solid tumorsF Carnevale-Schianca, A Ricchiardi, A Capaldi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 29, 2000
Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host diseaseF Carnevale-Schianca, P Martin, K Sullivan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 23, 2011
153Samarium-EDTMP administration followed by hematopoietic stem cell support for bone metastases in osteosarcoma patientsM Berger, G Grignani, A Giostra, et al.
Bone Marrow Transplantation|April 21, 2009
Therapy with mycophenolate mofetil for refractory acute and chronic GVHDT Furlong, P Martin, M E D Flowers, et al.
ESMO Open|May 13, 2021
High BRAF variant allele frequencies are associated with distinct pathological features and responsiveness to target therapy in melanoma patientsE Berrino, A Balsamo, A Pisacane, et al.
British Journal of Cancer|March 13, 2014
Ipilimumab retreatment in patients with pretreated advanced melanoma: the expanded access programme in ItalyV Chiarion-Sileni, J Pigozzo, P A Ascierto, et al.
Pageof 1